| |
Mike:
I couldn't get to the PDF files when I last tried. I *know* that they are available, but I couldn't get to them today either. Try this link, select either EPO or Great Britain (the others work, but they're all dead today, and those are the two sites that I've used successfully in the past together with Japan), select PCT (WO) for a search, and enter "Gliatech" in the "applicant" field......
european-patent-office.org
Either that, or remind me again tomorrow, and I'll check to see if the servers are back up.
;-)
Thanks for that abstract! I hadn't logged onto Motley Fool for over a year, but I did such today to look at the GLIA thread. Somebody posted that they had sold because a surgeon friend who uses -L had another surgeon friend that opened a single patient and got the impression that scarring wasn't reduced. That is, this investor, in the face of data from both trials, sold their shares due to a report of a friend of a friend who looked at a single patient. That's what I call strong hands. Not!
I will leave my 12 month target at $60.
Cheers! Rick |
|
